Greatmark Investment Partners Inc. Has $19,644,000 Stake in Aflac Inc. (AFL)
Greatmark Investment Partners Inc. cut its position in Aflac Inc. (NYSE:AFL) by 1.7% during the second quarter, according to its most recent filing with the SEC. The fund owned 272,224 shares of the company’s stock after selling 4,586 shares during the period. Aflac comprises 8.8% of Greatmark Investment Partners Inc.’s portfolio, making the stock its largest position. Greatmark Investment Partners Inc. owned 0.07% of Aflac worth $19,644,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the company. Oakworth Capital Inc. boosted its stake in Aflac by 62.4% in the second quarter. Oakworth Capital Inc. now owns 1,835 shares of the company’s stock worth $127,000 after buying an additional 705 shares during the period. Trust Department MB Financial Bank N A raised its position in Aflac by 291.9% in the second quarter. Trust Department MB Financial Bank N A now owns 2,171 shares of the company’s stock worth $135,000 after buying an additional 1,617 shares in the last quarter. NN Investment Partners Holdings N.V. acquired a new position in Aflac during the first quarter worth $153,000. Capital Analysts LLC raised its position in Aflac by 159.4% in the second quarter. Capital Analysts LLC now owns 4,033 shares of the company’s stock worth $159,000 after buying an additional 2,478 shares in the last quarter. Finally, Quadrant Capital Group LLC raised its position in Aflac by 1.7% in the second quarter. Quadrant Capital Group LLC now owns 2,384 shares of the company’s stock worth $166,000 after buying an additional 40 shares in the last quarter. 62.87% of the stock is currently owned by institutional investors.
Shares of Aflac Inc. (NYSE:AFL) traded down 0.45% during trading on Tuesday, hitting $70.30. 1,910,614 shares of the stock traded hands. The firm’s 50-day moving average price is $72.36 and its 200-day moving average price is $70.60. The stock has a market cap of $28.79 billion, a PE ratio of 11.56 and a beta of 1.33. Aflac Inc. has a 12 month low of $54.57 and a 12 month high of $74.50.
Aflac (NYSE:AFL) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.71 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.68 by $0.03. The firm had revenue of $5.44 billion for the quarter, compared to the consensus estimate of $5.45 billion. Aflac had a net margin of 12.12% and a return on equity of 14.30%. The company’s revenue was up 2.8% on a year-over-year basis. During the same period last year, the firm earned $1.50 EPS. Analysts anticipate that Aflac Inc. will post $6.85 EPS for the current year.
A number of research analysts recently weighed in on the stock. Wells Fargo & Co. assumed coverage on shares of Aflac in a research note on Friday, September 23rd. They issued a “market perform” rating for the company. Zacks Investment Research upgraded shares of Aflac from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a research note on Tuesday, July 26th. Vetr lowered shares of Aflac from a “hold” rating to a “sell” rating and set a $70.50 price objective for the company. in a research note on Tuesday, July 12th. Deutsche Bank AG reiterated a “hold” rating and issued a $73.00 price objective (down from $75.00) on shares of Aflac in a research note on Monday, August 1st. Finally, FBR & Co reiterated a “hold” rating on shares of Aflac in a research note on Friday, July 29th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $70.21.
In related news, insider Audrey B. Tillman sold 1,500 shares of the firm’s stock in a transaction on Tuesday, August 30th. The shares were sold at an average price of $73.98, for a total transaction of $110,970.00. Following the completion of the transaction, the insider now directly owns 33,958 shares of the company’s stock, valued at $2,512,212.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Barbara K. Rimer sold 3,650 shares of the firm’s stock in a transaction on Monday, August 1st. The shares were sold at an average price of $71.74, for a total transaction of $261,851.00. Following the transaction, the director now directly owns 15,910 shares of the company’s stock, valued at $1,141,383.40. The disclosure for this sale can be found here. Insiders own 3.90% of the company’s stock.
Aflac Incorporated is a business holding company. The Company engaged in is supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S.
Receive News & Stock Ratings for Aflac Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac Inc. and related stocks with our FREE daily email newsletter.